Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 5/2015

01-05-2015 | Research Article

Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells

Authors: Hsin-Lien Huang, Whei-Ling Chiang, Pei-Ching Hsiao, Ming-Hsien Chien, Hui-Yu Chen, Wei-Chun Weng, Ming-Ju Hsieh, Shun-Fa Yang

Published in: Tumor Biology | Issue 5/2015

Login to get access

Abstract

Timosaponin AIII (TAIII) is a steroidal saponin isolated from Anemarrhena asphodeloides that has been shown to inhibit cell growth and induce apoptosis in cancer. However, the effect of TAIII on acute myeloid leukemia (AML) remains unclear. Here, the molecular mechanism by which TAIII-induced apoptosis affects human AML cells was investigated. The results showed that TAIII significantly inhibited cell proliferation of four AML cell lines (MV4-11, U937, THP-1, and HL-60). Furthermore, TAIII induced apoptosis of HL-60 cells through caspase-3, caspase-8, and caspase-9 activations and PARP cleavage in a dose- and time-dependent manner. Moreover, Western blot analysis also showed that TAIII increased phosphorylation of JNK1/2 and p38 MAPK in a dose-dependent manner. Inhibition of JNK1/2 by specific inhibitors significantly abolished the TAIII-induced activation of the caspase-8. Taken together, our results suggest that TAIII induces HL-60 cell apoptosis through JNK1/2 pathways and could serve as a potential additional chemotherapeutic agent for treating AML.
Literature
1.
Ravindranath MH, Ramasamy V, Moon S, Ruiz C, Muthugounder S. Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG). Evid Based Complement Alternat Med. 2009;6:523–30.CrossRefPubMed
2.
Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci. 2008;13:440–52.CrossRefPubMed
3.
Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res. 2005;19:649–51.CrossRefPubMed
4.
Kang YJ, Chung HJ, Nam JW, Park HJ, Seo EK, Kim YS, et al. Cytotoxic and antineoplastic activity of timosaponin A-III for human colon cancer cells. J Nat Prod. 2011;74:701–6.CrossRefPubMed
5.
Takeda Y, Togashi H, Matsuo T, Shinzawa H, Takeda Y, Takahashi T. Growth inhibition and apoptosis of gastric cancer cell lines by Anemarrhena asphodeloides Bunge. J Gastroenterol. 2001;36:79–90.CrossRefPubMed
6.
Tsai CH, Yang CW, Wang JY, Tsai YF, Tseng LM, King KL, et al. Timosaponin AIII suppresses hepatocyte growth factor-induced invasive activity through sustained ERK activation in breast cancer MDA-MB-231 cells. Evid Based Complement Alternat Med. 2013;2013:421051.PubMedPubMedCentral
7.
Lok CN, Sy LK, Liu F, Che CM. Activation of autophagy of aggregation-prone ubiquitinated proteins by timosaponin A-III. J Biol Chem. 2011;286:31684–96.CrossRefPubMedPubMedCentral
8.
King FW, Fong S, Griffin C, Shoemaker M, Staub R, Zhang YL, et al. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress. PLoS One. 2009;4:e7283.CrossRefPubMedPubMedCentral
9.
Lee B, Jung K, Kim DH. Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice. Pharmacol Biochem Behav. 2009;93:121–7.CrossRefPubMed
10.
11.
Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood. 2005;106:1154–63.CrossRefPubMed
12.
Bishop JF. The treatment of adult acute myeloid leukemia. Semin Oncol. 1997;24:57–69.PubMed
13.
Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, et al. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS One. 2012;7:e46853.CrossRefPubMedPubMedCentral
14.
Kang SH, Jeong SJ, Kim SH, Kim JH, Jung JH, Koh W, et al. Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling. PLoS One. 2012;7:e28706.CrossRefPubMedPubMedCentral
15.
Yang SF, Chen MK, Hsieh YS, Yang JS, Zavras AI, Hsieh YH, et al. Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food Chem Toxicol. 2010;48:1052–8.CrossRefPubMed
16.
Hsiao PC, Hsieh YH, Chow JM, Yang SF, Hsiao M, Hua KT, et al. Hispolon induces apoptosis through JNK1/2-mediated activation of a caspase-8, -9, and -3-dependent pathway in acute myeloid leukemia (AML) cells and inhibits AML xenograft tumor growth in vivo. J Agric Food Chem. 2013;61:10063–73.CrossRefPubMed
17.
Chen T, Wong YS. Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation. J Agric Food Chem. 2008;56:10574–81.CrossRefPubMed
18.
Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, et al. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1. Apoptosis. 2013;18:851–60.CrossRefPubMed
19.
Haydn JM, Hufnagel A, Grimm J, Maurus K, Schartl M, Meierjohann S. The MAPK pathway as an apoptosis enhancer in melanoma. Oncotarget. 2014;5:5040–53.CrossRefPubMedPubMedCentral
20.
Lee C, Zhang Q, Kozlowski J, Brendler C, Soares MB, Dash A, et al. Natural products and transforming growth factor-beta (TGF-β) signaling in cancer development and progression. Curr Cancer Drug Targets. 2013;13:500–5.CrossRefPubMed
21.
Chien MH, Ying TH, Hsieh YS, Chang YC, Yeh CM, Ko JL, et al. Dioscoreanipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix metalloproteinase-2 through modulation of CREB and AP-1 activity. Food Chem Toxicol. 2012;50:558–66.CrossRefPubMed
22.
Li X, Wang H. Chinese herbal medicine in the treatment of chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:276–81.CrossRefPubMed
23.
Jia W, Gao W, Tang L. Antidiabetic herbal drugs officially approved in China. Phytother Res. 2003;17:1127–34.CrossRefPubMed
24.
Zhou F, Hao YF, Chen Y, Wang T. Chinese herbal medicine in treatment of polyhydramnios:a meta-analysis and systematic review. Chin Med Sci J. 2013;28:72–81.CrossRefPubMed
25.
Wei S, Fukuhara H, Chen G, Kawada C, Kurabayashi A, Furihata M, et al. Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo. Pathobiology. 2014;81:123–32.CrossRefPubMed
26.
Jagadeesan J, Nandakumar N, Rengarajan T, Balasubramanian MP. Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma. J Environ Pathol Toxicol Oncol. 2012;31:121–9.CrossRefPubMed
27.
Sun Z, Huang X, Kong L. A new steroidal saponin from the dried stems of Asparagus officinalis L. Fitoterapia. 2010;81:210–3.CrossRefPubMed
28.
Wang N, Feng Y, Zhu M, Siu FM, Ng KM, Che CM. A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma. Biochim Biophys Acta. 1833;2013:2890–9.
29.
Sy LK, Yan SC, Lok CN, Man RY, Che CM. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells. Cancer Res. 2008;68:10229–37.CrossRefPubMed
30.
31.
Kim HS, Lee MS. Essential role of STAT1 in caspase-independent cell death of activated macrophages through the p38 mitogen-activated protein kinase/STAT1/reactive oxygen species pathway. Mol Cell Biol. 2005;25:6821–33.CrossRefPubMedPubMedCentral
32.
Chinkwo KA. Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells. J Ethnopharmacol. 2005;98:163–70.CrossRefPubMed
33.
Cai J, Liu M, Wang Z, Ju Y. Apoptosis induced by dioscin in Hela cells. Biol Pharm Bull. 2002;25:193–6.CrossRefPubMed
34.
Hsieh MJ, Tsai TL, Hsieh YS, Wang CJ, Chiou HL. Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines. Arch Toxicol. 2013;87:1927–37.CrossRefPubMedPubMedCentral
35.
Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 2007;14:44–55.CrossRefPubMed
36.
37.
Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, et al. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells. Cancer Res. 2001;61:5106–15.PubMed
38.
39.
Park SJ, Kim IS. The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells. Br J Pharmacol. 2005;146:506–13.CrossRefPubMedPubMedCentral
40.
Yi L, Ji XX, Lin M, Tan H, Tang Y, Wen L, et al. Diallyl disulfide induces apoptosis in human leukemia HL-60 cells through activation of JNK mediated by reactive oxygen. Pharmazie. 2010;65:693–8.PubMed
41.
Su JL, Lin MT, Hong CC, Chang CC, Shiah SG, Wu CW, et al. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis. 2005;26:1–10.CrossRefPubMed
Metadata
Title
Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells
Authors
Hsin-Lien Huang
Whei-Ling Chiang
Pei-Ching Hsiao
Ming-Hsien Chien
Hui-Yu Chen
Wei-Chun Weng
Ming-Ju Hsieh
Shun-Fa Yang
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2985-7

Other articles of this Issue 5/2015

Tumor Biology 5/2015 Go to the issue

Research Article

Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colonization in lung adenocarcinoma

Research Article

The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis

Research Article

ALCAM is indirectly modulated by miR-125b in MCF7 cells

Research Article

Involvement of NEDD9 in the invasion and migration of gastric cancer

Research Article

Meta-analysis comparing the safety and efficacy of metastatic colorectal cancer treatment regimens, capecitabine plus irinotecan (CAPIRI) and 5-fluorouracil/leucovorin plus irinotecan (FOLFIRI)

Research Article

A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits